Acceleron Signs Deals for Bone-Forming Compounds
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 93 (Table of Contents)
Published: 8 Mar-2008
DOI: 10.3833/pdr.v2008.i93.205 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Acceleron Pharma entered into research and development agreement with Celgene for Acceleron’s ACE-011 that is in phase 1 clinical trials for treating cancer-related bone loss due to multiple myeloma, bone metastases of solid tumors or cancer treatments...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS